Registry for people with cerebral small vessel disease.
Official title: Real-world Patient Registry Study of Cerebral Small Vessel Disease
Run by Dongzhimen Hospital, Beijing · NCT07342075 · Data updated 2026-11-12
This project will collect clinical information and MRI scans from people aged 50 and older with MRI signs of cerebral small vessel disease to see how the condition relates to thinking, walking, and daily function over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Dongzhimen Hospital, Beijing Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | November 13, 2025 |
| Main results expected | August 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT07342075 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 50 or older with MRI-confirmed typical imaging changes of cerebral small vessel disease who can provide informed consent and attend the Beijing study site.
✕Probably not a fit
People with recent acute ischemic stroke or intracranial hemorrhage, significant non-vascular white matter disease, other known causes of cognitive impairment, or severe organ failure are excluded and therefore unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational registry enrolling adults aged 50 and older with MRI-confirmed cerebral small vessel disease. Participants will undergo standardized MRI (including diffusion tensor imaging), clinical evaluations, and cognitive testing at baseline and at planned follow-up visits to track changes over time. Key exclusions include recent large stroke or intracranial hemorrhage, significant non-vascular white matter disease, and other known causes of cognitive impairment to keep the cohort specific to CSVD. Collected data aim to link imaging features with clinical and cognitive outcomes to inform future targeted interventions.
Why it matters
Potential benefit: If successful, the registry could improve diagnosis and prognosis of CSVD and help researchers design targeted treatments for CSVD-related cognitive decline.
How similar studies have gone: Previous observational registries and imaging studies have linked CSVD imaging markers to cognitive and motor outcomes, but registry data have not yet produced proven targeted therapies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age above 50 years (including 50-year-old); 2. MRI confirmed the presence of typical imaging changes of CSVD; 3. Voluntary participation in the study and be willing to sign the Informed Consent Form. Exclusion Criteria: 1. Patients with acute ischemic stroke or acute intracranial hemorrhage (e.g., epidural hematoma, subdural hematoma, subarachnoid hemorrhage, intracerebral hemorrhage, etc.) or a history of cerebral infarction (non-lacunar) or intracranial hemorrhage within the past 3 months; 2. Significant non-vascular white matter lesions (e.g., multiple sclerosis, adult-onset leukoencephalopathy, metabolic encephalopathy, etc.); 3. Patients with a history of cognitive impairment due to other causes (e.g., normal pressure hydrocephalus, Alzheimer's disease, Parkinson's disease, multiple sclerosis, encephalitis, etc.); 4. Severe hepatic, renal, or cardiac insufficiency (ALT or AST \>2 times the upper limit of normal, or serum creatinine \>1.5 times the upper limit of normal, or New York Heart Association \[NYHA\] functional class III or IV); 5. Patients with psychiatric disorders that affect study medication administration and evaluation; 6. Contraindications to MRI examination (e.g., claustrophobia, presence of an implantable pacemaker, etc.); 7. Patients unable to comply with follow-up examinations or other study procedures due to residential location or other reasons; 8. Participation in other clinical trial projects.
Where it's running
-
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Beida Ren, PhD
- Email: 18810900836@163.com
- Phone: +86-18810900836
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intermittent theta-burst brain stimulation to improve thinking in people with small vessel brain disease
This trial will try intermittent theta-burst stimulation (a form of noninvasive brain stimulation) to see if it helps cognition in people aged 45–80 with vascular cognitive impairment from cerebral small vessel disease.
-
Investigating the relationship between white matter hyperintensity shape and brain clearance in dementia
This study is trying to see how the shape of certain brain changes in older adults with small vessel disease relates to their thinking skills and dementia.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
-
Cardiovascular and Cognitive Health Initiative
This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.
-
Synbiotic blend of LA-5 and agave inulin for mild cognitive impairment
This pilot crossover study tests whether a synbiotic containing Lactobacillus acidophilus LA-5 and agave inulin can help adults aged 60–75 with mild cognitive impairment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.